DocGo Inc. Common Stock Earnings Recaps
Q3 2025
Nov 11, 2025
DocGo's Q3 2025 results reflect strong operational momentum with record volumes across key business segments, underpinned by a robust balance sheet and strategic acquisition plans. The company anticipates significant growth in 2026, projecting revenues of $280 million to $300 million.
Key takeaways
- Achieved record volumes in medical transportation, driven by long-term contracts, with expectations to surpass $200 million in revenue for 2025.
- Announced acquisition of SteadyMD, expected to enhance growth in virtual care services and contribute $5 million to revenue in 2025.
- 2026 revenue guidance suggests 12%-20% growth year-over-year, with a path to adjusted EBITDA positive run rate by year-end.
- Targeted hiring initiatives in the EMS sector aim to capture additional revenue and improve service capacity.
- Multiple service lines are contributing positively to adjusted EBITDA, highlighting operational efficiency despite corporate overhead costs.
Q2 2025
Aug 8, 2025
DocGo delivered strong performance in Q2 2025, highlighted by a substantial cash flow increase and strategic cost reductions, positioning the company for growth amid increasing demand for proactive healthcare solutions.
Key takeaways
- Cash flow from operations exceeded $30 million, contributing to a total cash balance of $128.7 million at quarter-end.
- Implementation of substantial SG&A reductions is projected to generate $10 million in annualized savings.
- Operational metrics met targets with over 176,000 medical transports and significant progress in care gap closure programs.
- Customer engagement has surged, with over 1.2 million assigned lives served, and a 50% increase in patient conversions compared to the prior quarter.
- Ongoing expansion efforts with significant contracts in new markets position DocGo for robust growth through 2026.